Vitura Health Limited
ASX: VIT.AX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Ryan J. Tattle
- Employees
- 72
- Headquarters
- South Yarra, Australia
- IPO year
- 2019
- Market cap
- A$24.5M
- Website
- https://vitura.com.au
Loading VIT…
Loading profile data…Frequently asked questions about VIT
What does Vitura Health Limited (VIT.AX) do?
Vitura Health Limited engages in the sale and distribution of medicinal cannabis products in Australia and Asia. Its brands include CanView, Burleigh Heads Cannabis, CDA Clinics, Cannadoc, and Adaya. The company was formerly known as Cronos Australia Limited and changed its name to Vitura Health Limited in February 2023. The company was incorpor...
Where does VIT.AX trade?
Vitura Health Limited (VIT.AX) trades on the Australian Securities Exchange.
What sector is VIT.AX in?
Vitura Health Limited (VIT.AX) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Vitura Health Limited?
Ryan J. Tattle is the chief executive officer of Vitura Health Limited (VIT.AX).
Where is Vitura Health Limited headquartered?
Vitura Health Limited is headquartered in Australia.
Does VIT.AX pay a dividend?
Yes — Vitura Health Limited (VIT.AX) paid a trailing twelve-month dividend of AUD 0.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did VIT.AX go public?
Vitura Health Limited (VIT.AX) completed its initial public offering in 2019.